The Trade War’s Pharma Carve-Out
Both the U.S. and China have held off on tariffing each other’s pharmaceuticals.
U.S.-China Drugs Tie-ups Come Under Threat
A surge in dealmaking that's helped Chinese biotech and healthcare firms sell their products globally faces several headwinds.
China’s Tech Giants Look to Healthcare
Big tech companies see an opportunity in healthcare but making their businesses profitable has been a challenge to date.
Bad-tasting Medicine
Deep linkages exist between forced labor in Xinjiang and the global pharmaceutical supply chain, according to a new report.
Big Pharma Doubles Down on China
Foreign pharmaceutical firms are eyeing the world’s second largest market for profit opportunities as well as innovative assets.
WuXi Waylaid
When Congress resumes next month, the BioSecure Act will be one of its top priorities. The bill, which could dramatically reorder the global pharmaceutical supply...
China’s Ozempic Test
Novo Nordisk, the maker of Ozempic, has enjoyed a China boom in recent years, commanding 77 percent of the market. But that kind of dominance...
The Fentanyl Fix
The U.S. and China agreed to cooperate on fentanyl, but progress is proving hard to come by.
Dali Yang on the Mistakes Made In Covid’s Early Days
The political scientist and sinologist talks about the early days of the pandemic in Wuhan, and how the Chinese authorities’ lack of transparency led the...
A Crackdown Comes for Healthcare
Six months into a campaign to rout out corruption from the Chinese healthcare industry, many of the underlying issues in the sector remain unchanged.
The DNA Distortion
ANDE, a U.S. biotechnology company, promised a "faster way to a safer world" with its revolutionary rapid DNA testing machine. But by selling its innovation...
G42’s Ties To China Run Deep
More details on the Emirati technology firm at the nexus of China and the U.S.’s technological and geopolitical rivalry.